Recall another step in Merck slide
298813
Merck &amp; Co.'s decision to pull its widely prescribed drug Vioxx off the shelves yesterday because of a risk of stroke and heart attacks marked a new low for a pharmaceutical company that has suffered a steady decline in both market position and prestige over the last decade.
259440
Shares of Merck plunge after a Wall Street Journal article about the blockbuster arthritis medication. By Associated Press. WHITEHOUSE STATION, NJ - Shares of Merck &amp; Co.
538571
The Wall Street Journal reports Merck &amp; Co. of Whitehouse Station, NJ, has begun hunting for a new chief executive officer. The move comes amid a string of bad news at the drug maker, including its recent
521954
NEW YORK (CBS) The recent recall of the arthritis drug Vioxx has a lot of patients worried about the contents of their medicine cabinets and wondering what the alternatives might be.
523465
Merck &amp; Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the companyâs planned successor pill, Arcoxia, is safer.
73844
ANSWER: Cigna Medical Group has several more clinics scheduled (see box). Check with your doctor&#39;s office to see if they have ordered any new doses.
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
453249
Law &amp; Order: Pharmaceutical Unit. Merck (nyse: MRK - news - people ) Chief Executive Raymond V. Gilmartin may testify in some of the many lawsuits filed over the Vioxx recall, a company lawyer said.
29190
NEW YORK - The withdrawal of the arthritis drug Vioxx two weeks ago was a disaster for Merck. But it also put rival Pfizer in a fix.
79247
Merck &amp; Co., which withdrew the Vioxx painkiller last month because of a heart risk, said yesterday that US regulators have asked for more safety data before they will approve the medicine&#39;s successor, Arcoxia.
535194
Merck and Co. MRK.N suffered a  double blow on Friday when a court ruled that the patent on its  second-biggest drug will lapse a decade earlier than expected  and U.S. regulators elevated their probe of its withdrawn Vioxx  arthritis drug into a formal investigation.
195152
Merck &amp; Co. yesterday pulled the blockbuster pain medicine Vioxx off the market, announcing that a new company-sponsored study showed the drug doubled the risk
473820
As far as stock hits go, this ranks up there as one of the worst. Merck &amp; Co. lost more than $26.6 billion in value yesterday - yes, that&#39;s billion with ab - after the pharmaceutical giant
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
319815
Pharmaceutical giant Merck &amp; Co. abruptly ordered a worldwide recall of its premier arthritis drug Vioxx on Thursday after a company-run study confirmed that long-term use of the pills increased risk of heart attack and stroke.